Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Drug Compounding Market

Animal Drug Compounding Market Share

Report ID: GMI10492
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Animal Drug Compounding Market Share

The animal drug compounding industry is characterized by the blend of established pharmaceutical companies and specialized compounding pharmacies that shapes the competitive landscape. Leading companies emphasize innovation, quality control, and regulatory compliance to maintain their edge. The market includes both major pharmaceutical players and niche compounding service providers, each offering tailored solutions for various animal health needs. While dominant players leverage advanced technology and extensive distribution networks, smaller entities focus on personalized services and local expertise. This competition is further driven by advancements in veterinary medicine, regulatory changes, and the growing demand for customized treatments.

Animal Drug Compounding Market Companies

Few of the prominent players operating in the animal drug compounding industry include:

AVRIO Pharmacy
New Era Pharmacy
NexGen Pharmaceuticals
Pace Pharmacy
SaveWay Compounding Pharmacy
ScriptWorks
SCIRx Pharmacy
Summit Veterinary Pharmacy Ltd.
Triangle Compounding Pharmacy
The Pet Apothecary
Veterinary Pharmaceutical Solutions
Veterinary Specialty Pharmacy
WEDGEWOOD PHARMACY

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The animal drug compounding industry size was valued at USD 2.2 billion in 2023 and will grow at 8.3% CAGR from 2024 to 2032 due to increasing prevalence of chronic diseases among pets and livestock animals

The oral segment in the animal drug compounding industry is projected to record 8.1% CAGR during 2024-2032, as they are more palatable and can be easily customized to suit individual animal needs, enhancing compliance.

U.S. animal drug compounding market size was USD 1.3 billion in 2023 led by high pet ownership rates and substantial R&D investments

AVRIO Pharmacy, New Era Pharmacy, NexGen Pharmaceuticals, Pace Pharmacy, SaveWay Compounding Pharmacy, ScriptWorks, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd., and Triangle Compounding Pharmacy